Point72 Asset Management
BIVV

Point72 Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Point72 Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-194,500
Closed -$10.5M – 1244
2017
Q4 		$10.5M Buy
194,500
+53,500
+38% +$2.93M 0.05% 436
2017
Q3 		$8.05M Buy
+141,000
New +$8.26M 0.04% 446

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Point72 Asset Management's BIVV Position: Q1 2018 in Review

Point72 Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 194,500 shares — an estimated $10.5M sold.

Point72 Asset Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $10.5M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Point72 Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Point72 Asset Management sold 194,500 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $10.5M.
  • Point72 Asset Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Point72 Asset Management's Bioverativ Inc. Common Stock position peaked at $10.5M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Point72 Asset Management's 13F filing for Q1 2018, filed 15 May 2018.